The Antidepressant Era

★★★★★ 4.8 87 reviews

US$8.76
Price when purchased online
Free shipping Free 30-day returns

Sold and shipped by sgnewtech.com
We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here.
US$8.76
Price when purchased online
Free shipping Free 30-day returns

How do you want your item?
You get 30 days free! Choose a plan at checkout.
Shipping
Arrives Jul 2
Free
Pickup
Check nearby
Delivery
Not available

Sold and shipped by sgnewtech.com
Free 30-day returns Details

Product details

Management number 231960220 Release Date 2026/06/18 List Price US$8.76 Model Number 231960220
Category

When we stop at the pharmacy to pick up our Prozac, are we simply buying a drug? Or are we buying into a disease as well? The first complete account of the phenomenon of antidepressants, this authoritative, highly readable book relates how depression, a disease only recently deemed too rare to merit study, has become one of the most common disorders of our day-and a booming business to boot. The Antidepressant Era chronicles the history of psychopharmacology from its inception with the discovery of chlorpromazine in 1951 to current battles over whether these powerful chemical compounds should replace psychotherapy. An expert in both the history and the science of neurochemistry and psychopharmacology, David Healy offers a close-up perspective on early research and clinical trials, the stumbling and successes that have made Prozac and Zoloft household names. The complex story he tells, against a backdrop of changing ideas about medicine, details the origins of the pharmaceutical industry, the pressures for regulation of drug companies, and the emergence of the idea of a depressive disease. This historical and neurochemical analysis leads to a clear look at what antidepressants reveal about both the workings of the brain and the sociology of drug marketing. Most arresting is Healy's insight into the marketing of antidepressants and the medicalization of the neuroses. Demonstrating that pharmaceutical companies are as much in the business of selling psychiatric diagnoses as of selling psychotropic drugs, he raises disturbing questions about how much of medical science is governed by financial interest. Read more

ISBN10 0674039580
ISBN13 978-0674039582
Edition Revised ed.
Language English
Publisher Harvard University Press
Dimensions 6.14 x 0.83 x 9.25 inches
Item Weight 15.2 ounces
Print length 330 pages
Publication date November 15, 1999

Correction of product information

If you notice any omissions or errors in the product information on this page, please use the correction request form below.

Correction Request Form

Customer ratings & reviews

4.8 out of 5
★★★★★
87 ratings | 36 reviews
How item rating is calculated
View all reviews
5 stars
87% (76)
4 stars
2% (2)
3 stars
1% (1)
2 stars
0% (0)
1 star
10% (9)
Sort by

There are currently no written reviews for this product.